- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01752764
Assessment of the Relative Increase in Bioavailability of (Non-) Nutrients From a Mixed Salad by Adding Fat Containing Dressing
January 27, 2014 updated by: Unilever R&D
The hypothesis will be tested that fat can also increase absorption of (non)-nutrients from a salad.
Therefore we designed the current study to show an increase in relative absorption (bioavailability) of (non-) nutrients from a mixed salad by adding fat containing dressing.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Av. Dr. Enéas de Carvalho Aguiar, 44
-
São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 44, Brazil, SP - 05403-000
- Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo / Incor HC FM USP
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Main inclusion Criteria:
- Body mass index (BMI) ≥ 18.5 and ≤ 30.0 kg/m2.
- Apparently healthy: no medical conditions, no use of prescribed or over the counter drugs, which might affect study measurements (as judged by study physician)
- Haemoglobin within normal reference range as judged by the study physician.
- Total cholesterol, LDL cholesterol, HDL cholesterol and fasting triglycerides within the normal reference range, as judged by the study physician.
Main exclusion Criteria:
- Reported use of any medically- or self-prescribed diet at the moment of screening, or the intention to use any kind of diet in the period between screening and the end of the study.
- Reported weight loss or gain ≥ 10 % of bodyweight during a period of six months before screening.
- A known food allergy or intolerance.
- A dislike to the foods supplied during the study.
- Use of vitamins or supplements enriched with carotenoid and/or vitamin A and/of vitamin K.
- Known hypothyroidism or hyperthyroidism.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Test product
Test product: Salad with high dosage fat
|
|
|
Other: Control product
Control product: Salad with low dosage fat
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Area under the curve (AUC in nmol/l*h) of (non) nutrients
Time Frame: July 2013
|
Area under the curve (AUC in nmol/l*h) of (non) nutrients.
The AUCs are constructed from (non-) nutrient levels measured in plasma chylomicrons at the selected time-points.
The size of the areas under the curves will be compared between the test and control dressing.
|
July 2013
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dr. Raul C. Maranhão, M.D, Ph.D., Head Professor of Clinical Biochemistry, Faculty of Pharmaceutical Sciences Director, Lipid Metabolism Laboratory
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2013
Study Registration Dates
First Submitted
December 14, 2012
First Submitted That Met QC Criteria
December 14, 2012
First Posted (Estimate)
December 19, 2012
Study Record Updates
Last Update Posted (Estimate)
January 28, 2014
Last Update Submitted That Met QC Criteria
January 27, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- FDS-DRS-0573
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationNot yet recruiting
-
Central Hospital, Nancy, FranceNot yet recruitingHealthy SubjectsFrance
-
Lutroo Imaging LLCStanford UniversityRecruiting
Clinical Trials on Test product: Salad with a high dosage fat
-
Agroscope Liebefeld-Posieux Research Station ALPUniversity Hospital Inselspital, BerneCompletedInflammation | Obesity | Nutritional InterventionSwitzerland
-
Cumhuriyet UniversityHacettepe University Scientific Research Projects Coordination UnitCompletedAdolescent | Type 1 Diabetes MellitusTurkey (Türkiye)
-
Virginia Polytechnic Institute and State UniversityNational Center for Advancing Translational Sciences (NCATS)Completed
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsFrance
-
Malaysia Palm Oil BoardUniversity of MalayaCompletedInflammation | Insulin SensitivityMalaysia
-
Texas Tech UniversityPennington Biomedical Research Center; American Egg BoardCompletedDiabetes Mellitus, Type 2 | Insulin ResistanceUnited States
-
Corcept TherapeuticsCompleted
-
Stefania BasiliUniversity of Roma La SapienzaRecruitingNAFLD | NASH - Nonalcoholic SteatohepatitisItaly
-
Washington University School of MedicineCompletedMicrobiota | Gastrointestinal MicrobiomeUnited States
-
Laser Surgery CareQIAGEN Gaithersburg, IncCompletedAnal Cancer | Anal Canal HPV Infection Diagnosis | Anal Dysplasia DiagnosisUnited States